Cardiovascular Diseases Research in North Carolina
Cardiovascular Diseases Research (93.837) awarded $628 million to recipients in North Carolina in 487 grants from fiscal 2021 to 2025, 4.3% of the program's national total. University of North Carolina at Chapel Hill received the most, $259 million.
- Awarded in North Carolina$628 million
- Awards487
- Share of the program4.3%
- Rank among states8th of 51
- National total$15 billion
By year
| Fiscal year | Awards | Amount |
|---|---|---|
| FY 2021 | 232 | $118 million |
| FY 2022 | 246 | $127 million |
| FY 2023 | 237 | $125 million |
| FY 2024 | 248 | $126 million |
| FY 2025 | 244 | $132 million |
Recipients in North Carolina
| Recipient | Type | Awards | Amount |
|---|---|---|---|
| University of North Carolina at Chapel Hill | Colleges and universities | 203 | $259 million |
| Duke University | Colleges and universities | 178 | $229 million |
| Wake Forest University Health Sciences | Colleges and universities | 35 | $50.3 million |
| Research Triangle Institute | Nonprofits | 10 | $31.4 million |
| North Carolina State University | Colleges and universities | 10 | $11.5 million |
| Baebies, Inc. | Small businesses | 5 | $9.4 million |
| East Carolina University | Colleges and universities | 7 | $8.3 million |
| Eydis Bio, Inc. | Small businesses | 2 | $3.2 million |
| Geneventiv Therapeutics, Inc. | Small businesses | 1 | $2.5 million |
| Parion Sciences, Inc | Small businesses | 1 | $2.3 million |
Open opportunities under this program
- Emerging Global Leader Award (K43 Independent Clinical Trial Not Allowed)
- Emerging Global Leader Award (K43 Independent Clinical Trial Required)
- NIH Research Software Engineer (RSE) Award (R50 Clinical Trials Not Allowed)
- Academic Research Enhancement Award (AREA) for Undergraduate-Focused Institutions (R15 Clinical Trial Required)
- Intervention Research to Improve Native American Health (R01 Clinical Trial Optional)
- NHLBI Early Phase Clinical Trials for Therapeutics and/or Diagnostics for HLBS Disorders (R33 CT Required)
- NHLBI Early Phase Clinical Trials for Therapeutics and/or Diagnostics for HLBS Disorders (R61/R33 Clinical Trial Required)
- Continuation of the Cardiovascular Repository for-Type 1 Diabetes (CARE-T1D) Consortium U01 (Open Competition)- Research (U01, Clinical Trial Not Allowed)
- NHLBI Clinical Trial Pilot Studies (R34 Clinical Trial Optional)
- NIH, CDC and FDA Small Business Innovation Research Grant (Parent SBIR [R43/R44] Clinical Trial Optional)
See all 82 on the program page
Questions people ask
How much Cardiovascular Diseases Research money goes to North Carolina?
$628 million from fiscal 2021 to 2025, across 487 awards. North Carolina ranks 8th of 51 states and territories for this program.
Who receives Cardiovascular Diseases Research money in North Carolina?
The largest recipient is University of North Carolina at Chapel Hill, with $259 million in 203 awards. Next are Duke University and Wake Forest University Health Sciences.
Can organizations in North Carolina apply now?
Yes, 82 opportunities under this program are open or forecast on Grants.gov. Federal grants are national, so eligibility depends on the notice, not the state.
Cardiovascular Diseases Research in other states
Other large programs in North Carolina
- Grants to States for Medicaid
- Highway Planning and Construction
- Education Stabilization Fund
- National School Lunch Program
- Children's Health Insurance Program
- USAID Foreign Assistance for Programs Overseas
- Disaster Grants - Public Assistance (Presidentially Declared Disasters)
- Child Care and Development Block Grant
- Title I Grants to Local Educational Agencies
- Special Education Grants to States